Drawing for LIFE DISCOVERED. LIFE DIAGNOSED.

USPTO serial 87905886

LIFE DISCOVERED. LIFE DIAGNOSED.

Reviewed by CopyMark Law Group

Reg. 5898110Status 702Registered
Filing date
Status date
Registration date
Oct 29, 2019
Examiner
LEE, REBECCA ANN
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with LIFE DISCOVERED. LIFE DIAGNOSED.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

J. Michael Hurst

J. Michael Hurst KEATING MUETHING & KLEKAMP PLLONE EAST FOURTH STREET, SUITE 1400CINCINNATI, OH 45202United States

Goods and services

ClassDescriptionStatusFirst use
001diagnostic reagents for scientific use; reagents for scientific or medical research use; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemicals for use in the purification of proteins for in vitro use; protein in raw material form for scientific and medical research; enzymes for scientific and research purposesACTIVEJan 1, 2018
005diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents; clinical medical reagents; reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; protein arrays for medical diagnosis purposes; enzyme preparations for medical purposesACTIVEJan 1, 2018
010medical diagnostic machines, namely, immunoassay readers used to detect and measure antigens and antibodies; medical diagnostic instruments for the analysis of body fluids; sample preparation device for medical diagnostic uses; medical diagnostic apparatus for detecting gastrointestinal diseases, viral diseases, urinary diseases, respiratory diseases, and infectious diseasesACTIVEJan 1, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 10, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 10, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 10, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 3, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Oct 29, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 29, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 24, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 23, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 20, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 20, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 27, 2019IUAFUSE AMENDMENT FILED—
Aug 27, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 19, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 15, 2019EX1GSOU EXTENSION 1 GRANTED—
Mar 15, 2019EXT1SOU EXTENSION 1 FILED—
Mar 15, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 18, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 24, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 24, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 4, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 14, 2018ALIEASSIGNED TO LIE—
May 30, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 30, 2018XAECEXAMINER'S AMENDMENT ENTERED—
May 30, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 30, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
May 30, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
May 29, 2018DOCKASSIGNED TO EXAMINER—
May 12, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 7, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance